What if the very test meant to save your life could be subtly increasing your risk of cancer? That’s the alarming question emerging from new research on the widespread use of CT (computed tomography) scans—advanced imaging tools that use X-rays to generate cross-sectional views of the body. Often hailed for their ability to catch internal injuries, tumors, and other critical conditions early, CT scans have become a routine part of modern diagnostics. Yet as their use skyrockets globally, so do concerns over the health consequences of repeated and, at times, unnecessary exposure to high doses of radiation.
There’s no denying the clinical value of CT scans. They help detect life-threatening bleeding, guide surgeons during complex procedures, and monitor the progression of diseases like cancer. In the U.S. alone, over 93 million CT scans are performed each year—a number that continues to grow, according to medical market research firm IMV.
But what often goes unnoticed is the invisible cost: radiation exposure.
Unlike conventional x-rays, which emit lower doses, CT scans deliver substantially higher radiation levels. A chest x-ray, for instance, exposes a patient to 0.1 millisieverts (mSv), whereas a chest CT scan delivers around 7 mSv—that’s 70 times more. These numbers are not trivial, especially when stacked up over multiple scans throughout a person’s life.
One of the most concerning revelations from a study led by Dr. Rebecca Smith-Bindman, professor at the University of California, San Francisco, is the staggering inconsistency in radiation doses across CT machines. The dose for the same scan type can vary by a factor of 10 to 15 times, even when used for identical clinical reasons.
“In some cases, one machine could be exposing patients to tenfold more radiation than another,” Dr. Smith-Bindman told NBC News. This lack of regulation means patients could be unknowingly absorbing dangerous levels of radiation, increasing their long-term cancer risk.
Her 2009 study, which analyzed the 11 most common CT scan types in over 1,000 patients, found that radiation doses for an abdominal and pelvic scan could range up to 31 mSv—comparable to about 163 chest x-rays or 160 roundtrip flights between New York and Tokyo.
The link between medical radiation and cancer is not new, but its scale is only now becoming clear. According to findings published in The New England Journal of Medicine, CT-related radiation could be responsible for up to 2% of all cancers—translating to tens of thousands of cases annually.
Dr. Smith-Bindman’s team estimated that one in 270 women and one in 600 men who undergo certain types of CT scans at age 40 may develop cancer as a direct result of the scan. For younger patients in their 20s, the risk doubles.
Radiation has long been associated with cancers such as leukemia, breast, colon, ovarian, bladder, stomach, and lung cancers. With rising CT scan usage and no uniform standard for radiation dosing, experts warn we could be looking at a silent, radiation-fueled cancer epidemic in the coming decades.
Part of the answer lies in defensive medicine—doctors fearing lawsuits may order extra tests “just to be safe.” Financial incentives also play a role; CT scans are among the most expensive diagnostic tools, and hospitals benefit when more of them are used. This creates a dangerous mix of overdiagnosis and overexposure.
A separate long-term study from Brigham and Women’s Hospital in Boston analyzed over 31,000 patients and found that 33% had received more than five CT scans, and 1% had more than 38. In such cases, the cancer risk spiked to over 12% above the national average.
Recognizing the growing threat, the U.S. government is beginning to take action. New Medicare regulations, introduced during the final weeks of the Biden administration, require hospitals and imaging centers to record and share radiation dosage data from CT scanners. These rules will be phased in over three years and could include fines for non-compliance by 2027.
Whether these policies survive under subsequent administrations remains to be seen, but experts agree that standardization of CT scanning practices is urgently needed.
While some CT scans are medically necessary and lifesaving, patients can—and should—take steps to minimize unnecessary exposure:
Ask questions: Before undergoing a CT scan, ask your doctor how the results will influence your care. Could a lower-dose scan like an MRI or ultrasound provide the same insight?
Track your imaging history: Keep a personal record of all diagnostic scans you've had. It helps doctors make better-informed decisions and avoid redundant testing.
Consider spacing out scans: If you're undergoing routine imaging for a chronic condition, discuss with your provider whether extending the interval between scans is possible.
Avoid "just in case" scans: CT scans should not be used as reassurance tools in asymptomatic individuals, as they can lead to incidental findings, triggering a cycle of further tests and radiation exposure.
CT scans have revolutionized medical diagnostics and undoubtedly saved countless lives. But with great power comes great responsibility. The lack of regulation, wide dose variation, and rising use of these high-radiation scans call for a reevaluation of when and how they are used.
As science continues to uncover the long-term impact of medical imaging, one thing is clear: it’s time for the medical community—and patients themselves—to weigh not just the benefits, but the hidden risks, of overexposure to radiation.
Credits: Canva
In a landmark decision, the U.S. Food and Drug Administration (FDA) has approved the use of the SAPIEN 3 transcatheter aortic valve replacement (TAVR) platform for patients with severe aortic stenosis who show no symptoms. This is the first-ever approval of TAVR therapy for asymptomatic patients, marking a significant shift in how this life-threatening condition may be treated going forward.
Aortic stenosis is a narrowing of the aortic valve opening, which restricts blood flow from the heart to the rest of the body. In severe cases, the heart must work harder to pump blood, which can eventually lead to heart failure. While some patients experience chest pain, breathlessness, or fainting, others show no outward symptoms despite the seriousness of the condition.
The danger lies in the unpredictability—many asymptomatic patients may suddenly deteriorate, experiencing life-threatening events without warning. Until now, clinical guidelines advised “watchful waiting” for these patients, meaning treatment was delayed until symptoms appeared.
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that replaces the narrowed aortic valve without the need for open-heart surgery. The SAPIEN 3 is a next-generation TAVR device developed by Edwards Lifesciences. It is inserted via a catheter, usually through the femoral artery in the leg, and guided to the heart, where it expands and takes over the function of the diseased valve.
SAPIEN 3 is already widely used in patients with symptomatic severe aortic stenosis. With this new FDA approval, its use extends to a new, broader population of asymptomatic patients.
The decision was largely based on findings from the EARLY TAVR trial, a randomized clinical study that enrolled over 900 patients with severe aortic stenosis who had no symptoms. Participants were divided into two groups: one received TAVR using the SAPIEN 3 valve, while the other was monitored with watchful waiting.
After a median follow-up of 3.8 years, the trial found that:
The FDA’s approval of the SAPIEN 3 platform for asymptomatic severe aortic stenosis patients could lead to changes in clinical guidelines, encouraging earlier evaluation and treatment.
“There is an urgent need to change practice and TAVR guidelines,” said Dr. Philippe Genereux of Morristown Medical Center, who was involved in the EARLY TAVR trial. He emphasized that patients who seem stable can become symptomatic without warning, and early TAVR offers an opportunity to improve outcomes and ease the burden on the health care system.
Credits: Canva
Poultry-related outbreak has been on going in the US, especially with the ever on going bird flu. Recently, yet another outbreak has been associated with backyard poultry which has sickened at least seven people in six states. This is the new salmonella outbreak. The health officials have confirmed its news this Monday.
As per the Centers for Disease Control and Prevention (CDC), two cases were identified in Missouri, and one each in Florida, Illinois, South Dakota, Utah and Wisconsin.
The CDC noted that most people started falling sick in February and March of this year. All of them had the same strain of salmonella, which is a version that has been traced to hatcheries in the past. The health officials confirmed that investigation with regards to this recent outbreak is on going.
As per the US Food and Drugs Administration (FDA), Salmonella are a group of bacteria that can cause gastrointestinal illness and fever called salmonellosis. It can be spread by food handlers who do not wash their hands and/or the surfaces and tools they use between food preparation steps. It can also happen when people consume uncooked and raw food. Salmonella can also spread from animal to people.
FDA notes that people who have direct contact with certain animals, including poultry and reptiles can spread the bacteria from the animal to food if hand washing hygiene is not practiced.
Pets too could spread the bacteria within the home environment if they eat food contaminated with Salmonella.
Salmonella bacteria leads to infections in around 1.35 people in the United States, every year. However, the source does not always remain poultry. As per the CDC website Salmonella outbreaks previously have been linked with cucumbers, pet bearded dragons or gecko, eggs, small turtles, poultry, charcuterie meat, cantaloupes, diced onions, cookie dough, and flour.
The biggest concern with backyard poultry is that even if the chickens look clean and healthy, they could still carry salmonella bacteria. A backyard poultry associated outbreak which ended last year caused 470 cases, which were spread across 48 states and including one death.
FDA notes that most people infected with Salmonella will begin to develop symptoms 12 to 72 hours of the infection, which lasts for about four to seven days. Most people recover without treatment.
As per the CDC, each year, around 450 people diet in the United States due to acute salmonellosis.
Children who are younger than five and the elderly, and people with weakened immune system could be more at risk to have severe salmonellosis infections.
Credit: Canva
United States is experiencing its deadliest flu season for children in 15 years, according to a federal report released Friday. The Centers for Disease Control and Prevention (CDC) has reported 216 pediatric deaths so far this flu season—surpassing last year's 207 fatalities and marking the highest number since the 2009-2010 H1N1 pandemic.
The season is not yet over, making this already grim milestone even more concerning. In fact, the final death toll for the 2023-2024 flu season won’t be confirmed until later this year. "This number that we have now is almost certainly an undercount,” said Dr. Sean O’Leary of the American Academy of Paediatrics. “When the season is declared over, and they compile all the data, it’s almost certain to go up.”
O’Leary, who is also a pediatric infectious diseases specialist at the University of Colorado, pointed to declining flu vaccination rates among children as a key factor in this season’s severity. Over the past five years, the flu vaccination rate for children in the U.S. has dropped from about 64 per cent to just 49 per cent.
While flu vaccines do not always prevent infection, they are highly effective at reducing hospitalisations and deaths. "Flu vaccinations may not prevent people from coming down with symptoms, but research shows they are highly effective at preventing hospitalisations and deaths," O’Leary said.
This flu season has proven severe not only for children but for the general population as well. CDC estimates indicate at least 47 million illnesses, 610,000 hospitalisations, and 26,000 deaths so far. Among 5,200 adults hospitalised with the flu, 95 per cent had at least one pre-existing condition. In contrast, among 2,000 hospitalised children with more detailed health data, only about 53 per cent had underlying health issues such as asthma or obesity.
The CDC report did not include information on how many of the children who died had received the flu vaccine. Additionally, the agency did not provide a spokesperson to discuss the current season’s trends.
There is, however, a positive sign: flu activity has been declining since February. Last week, all 50 states reported low or minimal flu activity. The season also saw an unusual mix of circulating strains, with both H1N1 and H3N2 Type A viruses contributing significantly to infections. Earlier CDC data suggested that the flu vaccines offered this season were relatively effective in preventing hospitalisations and deaths.
The CDC continues to advise that everyone aged 6 months and older receive an annual flu vaccine.
The broader decline in childhood vaccinations is being fueled by online misinformation and the politicisation of vaccines, especially since the COVID-19 pandemic. Robert F. Kennedy Jr., who recently assumed the role of U.S. health secretary, has echoed antivaccine rhetoric, further influencing public opinion.
According to O’Leary, other factors may also be impacting flu vaccination rates. Pediatric clinics are often short-staffed and no longer holding as many after-hours vaccination events. Additionally, while more Americans are getting vaccinated at pharmacies, some drugstores do not offer flu shots for children.
"My hope is that this season will be a bit of a wake-up call for folks—that we actually do need to vaccinate our kids against influenza," O’Leary said.
© 2024 Bennett, Coleman & Company Limited